{"entity":{"type":"insider","cik":"0001610540","url":"/insider/0001610540","json_url":"/insider/0001610540.json","name":"Deerfield Mgmt III, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":208,"n_filings":50,"first":"2014-08-05","last":"2026-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Deerfield Mgmt III, L.P.","source":"filing","n_filings":50,"first_seen":"2014-08-05","last_seen":"2026-03-02"}],"transactions":[{"id":6136162,"accession":"0001193805-26-000205","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_display_name":"Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000000.0,"total_display":"25,000,000.00","total_whole":"25,000,000","shares_owned_after":6207982.0,"shares_owned_after_display":"6,207,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider","n_lines":4},{"id":5143787,"accession":"0001193805-25-001155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_display_name":"Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9375000.0,"shares_display":"9,375,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":30000000.0,"total_display":"30,000,000.00","total_whole":"30,000,000","shares_owned_after":9538945.0,"shares_owned_after_display":"9,538,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider","n_lines":3},{"id":4426836,"accession":"0001193805-25-000959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-25-000959","line_url":"/filing/0001193805-25-000959","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.","owner_display_name":"Deerfield Private Design Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":740149.0,"shares_display":"740,149","price_per_share":18.46,"price_display":"18.46","price_state":"stated","total_value":13663150.54,"total_display":"13,663,150.54","total_whole":"13,663,151","shares_owned_after":4887254.0,"shares_owned_after_display":"4,887,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider","n_lines":2},{"id":3218003,"accession":"0001193805-24-001348","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_display_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34814.0,"shares_display":"34,814","price_per_share":17.494786867352214,"price_display":"17.49","price_state":"stated","total_value":609063.51,"total_display":"609,063.51","total_whole":"609,064","shares_owned_after":5257329.0,"shares_owned_after_display":"5,257,329","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider","n_lines":4},{"id":3217981,"accession":"0001193805-24-001348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_display_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":528456.0,"shares_display":"528,456","price_per_share":18.04245197329579,"price_display":"18.04","price_state":"stated","total_value":9534642.0,"total_display":"9,534,642.00","total_whole":"9,534,642","shares_owned_after":5274736.0,"shares_owned_after_display":"5,274,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider","n_lines":4},{"id":2505760,"accession":"0001193805-24-000245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_display_name":"Deerfield Private Design Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4290617.0,"shares_display":"4,290,617","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":37499992.58,"total_display":"37,499,992.58","total_whole":"37,499,993","shares_owned_after":6151406.0,"shares_owned_after_display":"6,151,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider","n_lines":3},{"id":6667585,"accession":"0001193805-22-001817","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_display_name":"Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138872.0,"shares_display":"138,872","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":37495.44,"total_display":"37,495.44","total_whole":"37,495","shares_owned_after":1156309.0,"shares_owned_after_display":"1,156,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2022-12-30","scope":"insider","n_lines":3},{"id":6667581,"accession":"0001193805-22-001817","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_display_name":"Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141753.0,"shares_display":"141,753","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":36855.78,"total_display":"36,855.78","total_whole":"36,856","shares_owned_after":1218134.0,"shares_owned_after_display":"1,218,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider","n_lines":3},{"id":6667576,"accession":"0001193805-22-001817","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_display_name":"Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55610.0,"shares_display":"55,610","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":13902.5,"total_display":"13,902.50","total_whole":"13,903","shares_owned_after":1281242.0,"shares_owned_after_display":"1,281,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider","n_lines":3},{"id":6563897,"accession":"0001193805-22-001793","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_display_name":"Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65090.0,"shares_display":"65,090","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":17574.3,"total_display":"17,574.30","total_whole":"17,574","shares_owned_after":1305999.0,"shares_owned_after_display":"1,305,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-27","scope":"insider","n_lines":3},{"id":6563887,"accession":"0001193805-22-001793","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_display_name":"Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8294.0,"shares_display":"8,294","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":2322.32,"total_display":"2,322.32","total_whole":"2,322","shares_owned_after":1334976.0,"shares_owned_after_display":"1,334,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider","n_lines":3},{"id":6142077,"accession":"0001193805-22-001764","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13800.0,"shares_display":"13,800","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":4140.0,"total_display":"4,140.00","total_whole":"4,140","shares_owned_after":1338668.0,"shares_owned_after_display":"1,338,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider","n_lines":3},{"id":6142065,"accession":"0001193805-22-001764","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14740.0,"shares_display":"14,740","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":4569.4,"total_display":"4,569.40","total_whole":"4,569","shares_owned_after":1344812.0,"shares_owned_after_display":"1,344,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider","n_lines":3},{"id":6142053,"accession":"0001193805-22-001764","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99718.0,"shares_display":"99,718","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":28918.22,"total_display":"28,918.22","total_whole":"28,918","shares_owned_after":1351374.0,"shares_owned_after_display":"1,351,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider","n_lines":3},{"id":6142029,"accession":"0001193805-22-001734","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_display_name":"Flynn James E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3089.0,"shares_display":"3,089","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1204.71,"total_display":"1,204.71","total_whole":"1,205","shares_owned_after":1395768.0,"shares_owned_after_display":"1,395,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-15","scope":"insider","n_lines":3},{"id":6142016,"accession":"0001193805-22-001734","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_display_name":"Flynn James E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8600.0,"shares_display":"8,600","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":3268.0,"total_display":"3,268.00","total_whole":"3,268","shares_owned_after":1397143.0,"shares_owned_after_display":"1,397,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2022-12-14|6142007","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001374690","name":"Larimar Therapeutics, Inc.","url":"/issuer/0001374690","role":"Director, Ten percent owner, Other","n_filings":5,"first_seen":"2021-07-02","last_seen":"2026-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Ten percent owner","n_filings":2,"first_seen":"2024-11-13","last_seen":"2025-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001671818","name":"Oncorus, Inc.","url":"/issuer/0001671818","role":"Director, Ten percent owner, Other","n_filings":6,"first_seen":"2020-10-08","last_seen":"2022-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001522860","name":"Acutus Medical, Inc.","url":"/issuer/0001522860","role":"Director, Ten percent owner, Other","n_filings":2,"first_seen":"2020-08-12","last_seen":"2021-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001126234","name":"LUMOS PHARMA, INC.","url":"/issuer/0001126234","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2021-01-08","last_seen":"2021-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001534133","name":"GRAYBUG VISION, INC.","url":"/issuer/0001534133","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-10-01","last_seen":"2020-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Homology Medicines, Inc.","url":"/issuer/0001661998","role":"Director, Ten percent owner, Other","n_filings":6,"first_seen":"2018-04-04","last_seen":"2020-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001642545","name":"ShockWave Medical, Inc.","url":"/issuer/0001642545","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2019-03-11","last_seen":"2019-03-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2018-06-27","last_seen":"2019-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001655759","name":"ARVINAS INC.","url":"/issuer/0001655759","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2018-10-01","last_seen":"2018-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2017-10-10","last_seen":"2017-10-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001628738","name":"Audentes Therapeutics, Inc.","url":"/issuer/0001628738","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-07-25","last_seen":"2016-07-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-07-06","last_seen":"2016-07-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001652923","name":"AveXis, Inc.","url":"/issuer/0001652923","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-02-19","last_seen":"2016-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001650664","name":"Editas Medicine, Inc.","url":"/issuer/0001650664","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-02-08","last_seen":"2016-02-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Ten percent owner, Other","n_filings":8,"first_seen":"2015-10-09","last_seen":"2015-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001501989","name":"CytomX Therapeutics, Inc.","url":"/issuer/0001501989","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-10-14","last_seen":"2015-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001590877","name":"REGENXBIO Inc.","url":"/issuer/0001590877","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-09-22","last_seen":"2015-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001467652","name":"Neos Therapeutics, Inc.","url":"/issuer/0001467652","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-07-28","last_seen":"2015-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-05-13","last_seen":"2015-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001619087","name":"SteadyMed Ltd.","url":"/issuer/0001619087","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-03-25","last_seen":"2015-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-10-27","last_seen":"2014-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Avalanche Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-08-05","last_seen":"2014-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001610540","retrieved_at":"2026-08-23T09:31:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}